Gamunex-c 5 gram/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,843
Award facts
- Contract value 100% obligated
- $15,842.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,842.50 by the Defense Logistics Agency on January 20, 2026, for the supply of Gamunex-C 5 gram/50 milliliter vials. This competitive award, issued without set-aside designation, is structured as a firm fixed-price delivery order with an ultimate completion date of February 10, 2026. The contract is executed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement that runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which holds the overarching IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. The company's extensive federal contract portfolio demonstrates consistent capability in delivering specialized pharmaceutical products across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs. This delivery order for immunoglobulin therapy aligns with the company's established role as a critical vendor supplying specialty medications and medical commodities to federal defense and healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQU9W?
SPE2DR26FQU9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU9W worth?
The government has obligated $15,843 on SPE2DR26FQU9W.
Is contract SPE2DR26FQU9W an order under another contract?
Yes. SPE2DR26FQU9W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU9W competed?
The extent of competition for SPE2DR26FQU9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award